Meaningful and sustained weight loss and improvement of lipid profile in hypogonadal men on long-term treatment with testosterone undecanoate (TU) injections are independent of age: observational data from two registry studies

Sustained Weight Loss ◽

2084-P: Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-2084-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2084-P

Author(s):

AHMAD HAIDER ◽

KARIM S. HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Weight Loss ◽

Term Treatment ◽

Registry Study ◽

Sustained Weight Loss ◽

Hypogonadal men with cardiovascular diseases benefit from long-term treatment with testosterone undecanoate: observational data from a registry study

Endocrine Abstracts ◽

10.1530/endoabs.35.p478 ◽

2014 ◽

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Cardiovascular Diseases ◽

Observational Data ◽

Term Treatment ◽

Registry Study ◽

Substantial weight loss in 237 hypogonadal men with obesity class I-III under long-term treatment with testosterone undecanoate (TU): Observational real-life data from a registry study

Journal of Obesity & Weight loss Therapy ◽

10.4172/2165-7904.s1.015 ◽

2015 ◽

Vol 05 (04) ◽

Author(s):

Farid Saad

Keyword(s):

Weight Loss ◽

Real Life ◽

Term Treatment ◽

Registry Study ◽

Obesity Class ◽

Life Data ◽

Real Life Data ◽

Long‐term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

Obesity ◽

10.1002/oby.20407 ◽

2013 ◽

Vol 21 (10) ◽

pp. 1975-1981 ◽

Cited By ~ 92

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Weight Loss ◽

Term Treatment ◽

Sustained Weight Loss ◽

PD37-04 LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD): OBSERVATIONAL DATA FROM A REGISTRY STUDY

The Journal of Urology ◽

10.1016/j.juro.2015.02.2266 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Ahmad Haider ◽

Karim Sultan Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Cardiovascular Diseases ◽

Observational Data ◽

Term Treatment ◽

Registry Study ◽

MP32-17 162 HYPOGONADAL MEN WITH OBESITY RESPOND TO LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE WITH UNEXPECTED WEIGHT LOSS

The Journal of Urology ◽

10.1016/j.juro.2014.02.947 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Aksam Yassin ◽

Abdulmaged Traish ◽

Gheorghe Doros ◽

Farid Saad

Keyword(s):

Weight Loss ◽

Term Treatment ◽

Anthropometric and metabolic parameters in 46 hypogonadal men with obesity grade III improve upon long-term treatment with testosterone undecanoate (TU) injections: Observational data from two registry studies

Endocrine Abstracts ◽

10.1530/endoabs.35.p755 ◽

2014 ◽

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Aksam Yassin ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Observational Data ◽

Term Treatment ◽

Metabolic Parameters ◽

Long Term Treatment ◽

Grade Iii

Improvement of Type 2 Diabetes (T2DM) and Reduction of Major Adverse Cardiovascular Events and Mortality in Hypogonadal Men Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)—Real-Life Evidence from a Urological Registry Study

Diabetes ◽

10.2337/db18-111-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 111-LB

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Real Life ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

1124-P: Beneficial Changes in Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Registry

Diabetes ◽

10.2337/db19-1124-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1124-P

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Term Treatment ◽

178-OR: Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-178-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 178-OR

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Untreated Control ◽

Term Treatment ◽

Control Group ◽

Registry Study ◽

Untreated Control Group ◽